Metzler Genita, Dai Xuezhi, Thouvenel Christopher D, Khim Socheath, Habib Tania, Buckner Jane H, Rawlings David J
Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA 98101.
Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195.
J Immunol. 2017 Oct 1;199(7):2249-2260. doi: 10.4049/jimmunol.1700601. Epub 2017 Aug 11.
A common genetic variant in the gene encoding the protein tyrosine phosphatase nonreceptor type 22 ( C1858T) has been linked to a wide range of autoimmune disorders. Although a B cell-intrinsic role in promoting disease has been reported, the mechanism(s) through which this variant functions to alter the preimmune B cell repertoire remains unknown. Using a series of polyclonal and transgenic self-reactive models harboring the analogous mutation in murine , we show evidence for enhanced BCR, B cell-activating factor receptor, and CD40 coreceptor programs, leading to broadly enhanced positive selection of B cells at two discrete checkpoints in the bone marrow and spleen. We further identified a bias for selection of B cells into the follicular mature versus marginal zone B cell compartment. Using a biomarker to track a self-reactive H chain in peripheral blood, we found evidence of similarly enhanced positive selection in human carriers of the C1858T variant. Our combined data support a model whereby the risk variant augments the BCR and coreceptor programs throughout B cell development, promoting enrichment of self-reactive specificities into the follicular mature compartment and thereby likely increasing the risk for seeding of autoimmune B cell responses.
编码蛋白酪氨酸磷酸酶非受体22型(C1858T)的基因中的一种常见基因变异与多种自身免疫性疾病有关。尽管已有报道称其在促进疾病发生方面具有B细胞内在作用,但该变异改变免疫前B细胞库的机制仍不清楚。我们使用了一系列在小鼠中携带类似突变的多克隆和转基因自身反应模型,发现有证据表明BCR、B细胞激活因子受体和CD40共受体程序增强,导致骨髓和脾脏中两个离散检查点处B细胞的阳性选择广泛增强。我们进一步确定了B细胞向滤泡成熟B细胞与边缘区B细胞区室选择的偏向性。使用一种生物标志物追踪外周血中自身反应性重链,我们在C1858T变异的人类携带者中发现了类似增强的阳性选择的证据。我们的综合数据支持一种模型,即风险变异在整个B细胞发育过程中增强BCR和共受体程序,促进自身反应性特异性富集到滤泡成熟区室,从而可能增加引发自身免疫性B细胞反应的风险。